Vincent Rajkumar: Myeloma treatments increase lifespan, but are expensive

Vincent Rajkumar shared the following on X:

“Myeloma treatments have helped increase life span greatly, but they are expensive. Thankfully, affordable generic bortezomib and lenalidomide is available in most countries. Academic CART can greatly lower the price of CART further. Slide courtesy Nikhil Munshi.”

Source: Vincent Rajkumar/X

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group.  He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.